Does Preparation Really Affect Ketamine Outcomes? Yes.

How Set, Setting, and Preparation Shape Ketamine Outcomes

Set, setting, and preparation are distinct, evidence-based variables in psychedelic-assisted therapy. Set is your psychological state, expectations, and intentions going into a session. Setting is the physical and social environment around you. Readiness encompasses both of these elements, plus logistical and medical factors.

A 2025 systematic review by Estric et al. in the Journal of Psychopharmacology confirms that set and setting are foundational, evidence-backed variables in psychiatric outcomes for psychedelic-assisted therapies².

The convergence of findings across multiple peer-reviewed studies and care frameworks shows these variables are not new or speculative. While much of the evidence base comes from broader psychedelic-assisted therapy research, ketamine's neuroplasticity mechanism and medical use case make these findings directly applicable to ketamine therapy outcomes.

The Role of Psychological Set Before a Session

In a 2018 prospective study published in Frontiers in Pharmacology, researchers at Imperial College London tracked 654 adults across five time points, from one week before through four weeks after a planned psychedelic experience. The study set out to identify which pre-session variables predicted both the in-session experience and its lasting effects. The pre-session psychological state, what the researchers called the "set" component, emerged as the single strongest factor protecting against a difficult or distressing in-session experience.¹

The set component captured items like feeling comfortable about the upcoming experience, feeling well prepared, feeling ready to surrender to whatever arose, and the absence of pre-session anxiety. Its predictive effect against challenging experience scores was stronger than any other variable in the model, including drug dose (β = −0.324, p < 0.001 for set, compared with β = 0.219 for drug dose).¹ In practical terms, how prepared and settled someone felt going into a session mattered more for avoiding a difficult experience than how much medication they took.

A separate component the researchers called "clear intentions" tracked whether participants had concrete intentions and expectations going into the session. Clear intentions independently predicted the probability of having a mystical-type experience (β = 0.180, p = 0.013), which is the in-session quality most consistently linked to improvements in long-term well-being.¹ Mystical-type experience scores in turn predicted measurable well-being increases at both two weeks and four weeks post-session in the same dataset.

Acute challenging experiences were negatively associated with well-being scores (β = −1.435, p = 0.003),¹ reinforcing that distressing in-session states track with worse outcomes overall.

The takeaway is direct. A calm, prepared, intentional psychological state going into a session is not a soft variable. It is a measurable, modifiable predictor that the research has identified as one of the strongest determinants of how a session unfolds and what carries forward afterward.

The Role of Setting and Environment During a Session

The same Haijen prospective study identified the physical and social environment as a direct predictor of long-term well-being, distinct from psychological set or in-session experience. The "setting" component of the analysis captured three items: feeling comfortable in the physical environment of the session, having a good relationship with the people present, and trusting the person responsible for looking after the participant during the experience.

The setting component significantly predicted well-being two weeks after a session (β = 1.206, p = 0.037), with a similar trend at four weeks. What participants reported about their environment and the trustworthiness of the people in it directly shaped how they felt two weeks later, independent of drug dose, in-session experience, or baseline traits. The well-being increases across the full sample were substantial. Average scores on the Warwick-Edinburgh Mental Wellbeing Scale rose from 49.0 at baseline to 52.6 at two weeks and remained at 51.8 at four weeks (p < 0.001), with setting variables contributing meaningfully to that change.¹

A 2025 systematic review in the Journal of Psychopharmacology (Estric et al.) catalogued 27 clinical trials of psychedelic-assisted therapy in psychiatric populations and confirmed that rigorous setting protocols are now near-universal in modern research. Across the 763 participants in the reviewed trials, 100% of studies used careful participant selection, 80% included structured post-session integration, 72% had two trained monitors present, 76% used pre-defined music playlists, and 64% used eye masks to control visual distraction. Set and setting are no longer treated as soft adjuncts. They are baseline standards in psychedelic clinical research.

Estric et al. specifically noted that traditional ketamine therapy has historically been administered without comparable set and setting protocols, with sessions typically accompanied only by nursing supervision. Clinician-guided at-home ketamine therapy is designed to close that gap. A familiar home environment, a peer treatment monitor, structured preparation, and integration support apply the evidence base that decades of psychedelic research have established and that conventional ketamine practice has historically lacked. Whether this framework actually translates into different patient outcomes is no longer a theoretical question. The next section examines what peer-reviewed real-world outcomes data shows

The Role of Integration After a Session

After a ketamine session, integration is the third pillar that determines whether the experience translates into lasting change. Integration is the active process of consolidating in-session insights into durable behavioral and cognitive shifts, supported by reflection, journaling, and continued therapeutic engagement during the days and weeks that follow.

The Haijen prospective study found that well-being increases were sustained from two weeks (mean WEMWBS 52.6) to four weeks (51.8) post-session, suggesting that the post-session period itself shapes whether benefits endure. The study's authors specifically identified integration as a key but underexamined mechanism, noting that what participants did with their experience afterward likely accounted for differences in long-term outcome.

Estric et al. (2025) found that 80% of the 27 reviewed clinical trials of psychedelic-assisted therapy included structured post-session integration meetings, ranging from telephone follow-ups the day after the session to multi-week integration psychotherapy. Integration is not a niche practice. It is now standard methodology in psychedelic clinical research.

Practical integration content, including the 24-hour post-session protocol, journaling, ongoing coaching, and integration circles, is covered in the dedicated post-session section below. The point here is that integration is the third measurable, modifiable variable in the set, setting, and integration triad, and the one that determines whether the gains from a session actually translate into lasting change.

What Peer-Reviewed Outcomes Data Shows About Delivery Setting

The two largest peer-reviewed studies of Mindbloom's provider-guided at-home ketamine therapy reported depression response rates that met or exceeded those reported in selected published IV ketamine studies, although cross-study comparisons should be interpreted cautiously because study designs, patient populations, and outcome measures differ.

In a peer-reviewed real-world study, Hull et al. (2022) reported a 62.8% response rate for depression.³ Mathai et al. (2024) reported a 56.4% response rate.⁴ Both studies evaluated outcomes within a structured at-home sublingual ketamine protocol with clinical oversight, preparation, and integration support. Patient-population overlap with Mindbloom is disclosed in each study.

By comparison, McInnes et al. (2022), the largest published real-world analysis of community IV ketamine practices, reported a 53.6% response rate.⁵ These findings align with what the Haijen and Estric set/setting research would predict.^1,2 When the structured set, setting, and integration framework that classical psychedelic research has established is applied to ketamine delivery, response rates exceed those reported from community IV ketamine clinics that have historically lacked that framework. The gap between these at-home response rates and the community IV clinic figure is consistent with the magnitude of effect that set and setting variables have shown in prospective psychedelic studies.

How to Prepare for a Ketamine Session

Effective preparation spans medical, psychological, physical, and logistical steps, each taken before a ketamine session to optimize safety and therapeutic potential. It is a multi-step process that begins with medical screening and continues through the moments before the session starts.

The following five steps form a sequential, practical protocol. Each step addresses a different modifiable variable identified by the research discussed above. For at-home ketamine therapy, this process also includes setting up the physical space and confirming the peer treatment monitor's availability. Each of these steps is something you can control, and controllable preparation variables predict outcomes.

Step 1: Medical Screening and Session Plan

Preparation begins with an evaluation by a licensed provider who reviews your medical history, current medications, and psychiatric conditions to confirm eligibility. The assessment identifies contraindications such as uncontrolled hypertension, psychotic disorders, or substance use disorders.

Step 2: Intentions and Mindset

Before each session, identify a specific focus, question, or therapeutic goal to anchor your experience. It acts as a directional anchor rather than a rigid expectation of what will happen. Approaching the session with openness and clear intentions supports a state of surrender, which predicts positive therapeutic results.

Practical examples of intentions include:

• Emotional exploration: "I want to understand what is underneath my anxiety."
• Pattern interruption: "I want to notice the thought loops that keep me stuck."
• Openness: "I want to let go of needing to control the experience."

Mindbloom's guide coaching sessions include intention-setting support before each session. Setting directional intentions is more effective than setting rigid outcome expectations like "I will feel better."

Step 3: Set and Setting at Home

Creating a therapeutic environment at home requires attention to sensory details. The goal is to create conditions that mirror the perceived safety and comfort linked to positive long-term outcomes.

Key elements of physical setting include:

• Lighting: Dim the lights or use an eye mask to support inward focus.
• Sound: Use headphones with a therapeutic soundscape or calming music.
• Comfort: Arrange a comfortable place to recline with blankets, water, and a journal within reach.
• Distractions: Silence phone notifications, inform household members, and close unnecessary browser tabs.

Mindbloom provides custom soundscapes within its app-guided programs. The Bloombox also includes session essentials designed to support the physical setting.

Step 4: Body Basics: Food, Sleep, and Hydration

Physical readiness directly impacts how the session unfolds. Avoid eating for at least four hours before a session to reduce nausea risk, though light hydration is fine. Avoid alcohol and recreational substances in the 24 hours before treatment.

Prioritize a full night of sleep the night before, as poor sleep quality is associated with heightened anxiety and reduced capacity for openness. Afternoon or early evening sessions are typically recommended to align with circadian rhythms and protect sleep quality the night of treatment. Discuss specific timing with your provider based on personal response. Stay well-hydrated throughout the day but avoid large volumes of liquid immediately before the session.

Step 5: Support Plan and Safety Checklist

A peer treatment monitor is required to be present during every Mindbloom session. The monitor remains in the home and is available if you need anything during or immediately after the session. The peer treatment monitor is part of a safety protocol, not intoxication management.

A pre-session checklist helps ensure all logistical steps are complete:

• Peer treatment monitor confirmed and briefed.
• Session space prepared with lighting, sound, and comfort items.
• Phone silenced and calendar cleared for the session window.
• Provider consult completed and dosing confirmed.
• Intention identified.
• No driving planned until after a full night of sleep.

Mindbloom's app and guide messaging provide additional pre-session support and reminders.

What to Expect During a Ketamine Session

A ketamine session follows a general arc of onset, a peak experience window, and a gradual return to baseline. Onset typically occurs within 5 to 15 minutes depending on the administration method. Sessions are conducted at home with a peer treatment monitor present and medical oversight available.

Common experiences may include:

• Dissociation: The therapeutically meaningful shift in perspective that allows clients to observe thoughts and emotions from a new vantage point. Most people find the dissociative state therapeutically significant within a supervised setting. If the dissociative state feels unfamiliar, preparation materials and the peer treatment monitor can help navigate it.
• Altered perception: Changes in visual, auditory, or spatial awareness that are temporary and typically resolve within one to two hours.
• Emotional surfacing: Feelings, memories, or insights may arise as part of the therapeutic process.
• Physical sensations: Some people experience temporary nausea, dizziness, or changes in blood pressure, which are managed through care protocols.

Returning to your intention can reorient you if the experience feels unfamiliar. Rather than trying to direct what happens, research supports allowing the session to unfold while holding the intention loosely. The preparation completed before the session directly shapes the quality of what unfolds during it.

What to Do After a Ketamine Session: The First 24 Hours and Integration

Making sense of session insights and applying them to daily life is what clinicians call integration. The first 24 hours after treatment represent a critical window when neuroplastic changes are most active and new patterns of thinking are most accessible.

The post-session protocol involves practical steps for the first 24 hours:

• No driving or operating machinery until after a full night of sleep.
• Integration journaling within 24 hours to write down any images, feelings, insights, or shifts in perspective while they are fresh.
• Light social contact only to avoid major decisions, intense conversations, or high-stimulation environments.
• Rest as needed, as some people prefer to keep their schedule clear while others feel ready to resume non-driving activities later the same day.

Ongoing integration includes 1:1 guide coaching sessions and unlimited access to peer-led Group Integration Circles. Self-directed practices like journaling help consolidate insights between sessions. In a peer-reviewed real-world study of 11,441 patients, 61.4% of participants achieved clinically significant improvement in depression scores by week four, with some clients noticing changes within hours or days of their first session. Depression response rates of 56.4% to 62.8% across published peer-reviewed studies reflect cumulative benefits over a series of sessions,⁴ with session frequency personalized based on individual needs.

How Protocol-Driven Care Frameworks Support Ketamine Outcomes

Protocol-driven care frameworks sequence medical screening, preparation, supervised sessions, and integration support to maximize safety and therapeutic outcomes. Building on the medical screening and provider evaluation described in Step 1, responsible ketamine therapy maintains ongoing oversight throughout the treatment course.

Mindbloom is a specific, evidence-backed implementation of the framework, having facilitated over 800,000 supervised sessions. Two of the largest peer-reviewed, real-world outcomes studies of at-home ketamine therapy have been published in peer-reviewed journals.^3,4 In the larger of the two studies, an analysis of 11,441 patients, 61.4% of participants achieved clinically significant improvement in depression scores by week four, with a Cohen's d of 1.46.⁴ Across the two studies, depression response rates were 56.4% and 62.8%.^3,4 For comparative context, one of the largest published real-world analysis of community IV ketamine clinics reported a 53.6% response rate using the same primary outcome measure (PHQ-9 response) and the same retrospective study design.⁶ The structured care framework, applied to home-based delivery, may be one variable that distinguishes these outcomes.

Individual results may vary, and outcomes were measured using validated instruments like the PHQ-9 and GAD-7.

The evidence converges on a clear point: preparation, care structure, and integration are central to ketamine therapy's effectiveness. A protocol that addresses all three gives clients the strongest foundation for meaningful, lasting change.

Conclusion

Psychological readiness, set, setting, and integration are not supplementary to ketamine therapy. They are among the strongest predictors of outcomes, supported by a convergent body of peer-reviewed evidence. Every step, from medical screening to intention setting to creating a comfortable environment, is a modifiable variable that clients can act on.

Programs designed around these variables translate the research into a repeatable care framework. Mindbloom's provider-guided at-home model provides the necessary oversight and integration support to maximize neuroplastic windows.

Important Safety Information

Ketamine is not FDA-approved for PTSD, depression, or anxiety. Common side effects include dissociation, increased blood pressure, nausea, dizziness, and cognitive impairment. Ketamine has abuse potential and is not appropriate for patients with uncontrolled hypertension, psychotic disorders, or substance use disorders. Do not drive or operate machinery until the day after treatment. Individual results may vary. Full safety information: www.mindbloom.com/safety-information

Off-Label Use Disclosure

Ketamine is FDA-approved only as an anesthetic. Use for mental health conditions represents off-label prescribing by licensed clinicians based on clinical judgment. Schedule III Controlled Substance - DEA regulations apply.